Orca-T
A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 80 patients (estimated)
- Sponsors
- Orca Biosystems, Inc.
- Tags
- Allogeneic Stem Cell Transplant, T Cell (Allogeneic)
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2182
- NCT Identifier
- NCT07216443
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.